Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2

Outbreak of Coronavirus Disease 2019 (COVID-19) has become a great challenge for scientific community globally. Virus enters cell through spike glycoprotein fusion with ACE2 (Angiotensin-Converting Enzyme 2) human receptor. Hence, spike glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:In Silico Pharmacol
Autors principals: Rathod, Shravan B., Prajapati, Pravin B., Punjabi, Lata B., Prajapati, Kuntal N., Chauhan, Neha, Mansuri, Mohmedyasin F.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7649901/
https://ncbi.nlm.nih.gov/pubmed/33184600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40203-020-00055-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars